James E. Olson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
James E. Olson has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Singer
Department of Emergency Medicine Wright State University Dayton, OH
4 shared publications Eduardo Martinho
2 shared publications- Ana Y. Estevez
Biology Department, St. Lawrence University, Canton, NY 13617, USA
1 shared publication - Brian Tucker
Department of Neuroscience, Cell Biology, and Physiology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA
1 shared publication - Catherine A. Marco
Department of Emergency Medicine, Wright State University, Dayton, OH, United States of America
1 shared publication - Derek Broering
Wright State University, 3640 Colonel Glenn Hwy, Dayton, OH, USA 45435
1 shared publication
Latest Publications
- Open Access
- 3 October 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (10) , 562
Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA
Cerium oxide (CeO2) nanoparticles (CeNPs) are potent antioxidants that are being explored as potential therapies for diseases in which oxidative stress plays an important pathological role. However, both beneficial and toxic effects of CeNPs have been reported, and the method of synthesis as well as physico-chemical, biological, and environmental factors can impact the ultimate biological effects of CeNPs. In the present study, we explored the effect of different ratios of citric acid (CA) and EDTA (CA/EDTA), which are used as stabilizers during synthesis of CeNPs, on the antioxidant enzyme-mimetic and biological activity of the CeNPs. We separated the CeNPs into supernatant and pellet fractions and used commercially available enzymatic assays to measure the catalase-, superoxide dismutase (SOD)-, and oxidase-mimetic activity of each fraction. We tested the effects of these CeNPs in a mouse hippocampal brain slice model of ischemia to induce oxidative stress where the fluorescence indicator SYTOX green was used to assess cell death. Our results demonstrate that CeNPs stabilized with various ratios of CA/EDTA display different enzyme-mimetic activities. CeNPs with intermediate CA/EDTA stabilization ratios demonstrated greater neuroprotection in ischemic mouse brain slices, and the neuroprotective activity resides in the pellet fraction of the CeNPs. The neuroprotective effects of CeNPs stabilized with equal proportions of CA/EDTA (50/50) were also demonstrated in two other models of ischemia/reperfusion in mice and rats. Thus, CeNPs merit further development as a neuroprotective therapy for use in diseases associated with oxidative stress in the nervous system.
- 3 October 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (10) , 562
Open AccessAntioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA
Cerium oxide (CeO2) nanoparticles (CeNPs) are potent antioxidants that are being explored as potential therapies for diseases in which oxidative stress plays an important pathological role. However, both beneficial and toxic effects of CeNPs have been reported, and the method of synthesis as well as physico-chemical, biological, and environmental factors can impact the ultimate biological effects of CeNPs. In the present study, we explored the effect of different ratios of citric acid (CA) and EDTA (CA/EDTA), which are used as stabilizers during synthesis of CeNPs, on the antioxidant enzyme-mimetic and biological activity of the CeNPs. We separated the CeNPs into supernatant and pellet fractions and used commercially available enzymatic assays to measure the catalase-, superoxide dismutase (SOD)-, and oxidase-mimetic activity of each fraction. We tested the effects of these CeNPs in a mouse hippocampal brain slice model of ischemia to induce oxidative stress where the fluorescence indicator SYTOX green was used to assess cell death. Our results demonstrate that CeNPs stabilized with various ratios of CA/EDTA display different enzyme-mimetic activities. CeNPs with intermediate CA/EDTA stabilization ratios demonstrated greater neuroprotection in ischemic mouse brain slices, and the neuroprotective activity resides in the pellet fraction of the CeNPs. The neuroprotective effects of CeNPs stabilized with equal proportions of CA/EDTA (50/50) were also demonstrated in two other models of ischemia/reperfusion in mice and rats. Thus, CeNPs merit further development as a neuroprotective therapy for use in diseases associated with oxidative stress in the nervous system.
- 1 September 2015
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 33 (9) , 1201-1204
Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths
- 1 September 2015
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 33 (9) , 1201-1204
Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths
- Open Access
- 16 January 2013
- Published by Wiley in Academic Emergency Medicine
- Vol. 20 (2) , 217
Emeritus Professor Spot: Even Cajoled, He Don't Pull Shifts
- 16 January 2013
- Published by Wiley in Academic Emergency Medicine
- Vol. 20 (2) , 217
Open AccessEmeritus Professor Spot: Even Cajoled, He Don't Pull Shifts
- Open Access
- 31 July 2012
- Published by Wiley in Academic Emergency Medicine
- Vol. 19 (9) , E1117
To Triage, To Triage
- 31 July 2012
- Published by Wiley in Academic Emergency Medicine
- Vol. 19 (9) , E1117
Open AccessTo Triage, To Triage
- 14 March 2011
- Published by Wiley in Academic Emergency Medicine
- Vol. 18 (3) , 305-306
Twentieth Annual Midwest Regional SAEM Meeting: Award Winners*
- 14 March 2011
- Published by Wiley in Academic Emergency Medicine
- Vol. 18 (3) , 305-306
Twentieth Annual Midwest Regional SAEM Meeting: Award Winners*
- Open Access
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S10
Glutamate receptor-mediated taurine release from the hippocampus during oxidative stress
Hippocampal slices swell and release taurine during oxidative stress. The influence of cellular signalling pathways on this process is unclear. Glutamate signalling can facilitate volume regulation in other CNS preparations. Therefore, we hypothesize activation of taurine release by oxidative stress results from tissue swelling and is coupled to activation of glutamate receptors.
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S10
Open AccessGlutamate receptor-mediated taurine release from the hippocampus during oxidative stress
Hippocampal slices swell and release taurine during oxidative stress. The influence of cellular signalling pathways on this process is unclear. Glutamate signalling can facilitate volume regulation in other CNS preparations. Therefore, we hypothesize activation of taurine release by oxidative stress results from tissue swelling and is coupled to activation of glutamate receptors.
- Open Access
- 29 December 2008
- Published by Wiley in Academic Emergency Medicine
- Vol. 16 (1) , 49
Longevity Has Its Place and I’m Concerned About That Now
- 29 December 2008
- Published by Wiley in Academic Emergency Medicine
- Vol. 16 (1) , 49
Open AccessLongevity Has Its Place and I’m Concerned About That Now
- 1 December 2008
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 295 (6) , C1550-C1560
Purinergic activation of anion conductance and osmolyte efflux in cultured rat hippocampal neurons
The majority of mammalian cells demonstrate regulatory volume decrease (RVD) following swelling caused by hyposmotic exposure. A critical signal initiating RVD is activation of nucleotide receptors by ATP. Elevated extracellular ATP in response to cytotoxic cell swelling during pathological conditions also may initiate loss of taurine and other intracellular osmolytes via anion channels. This study characterizes neuronal ATP-activated anion current and explores its role in net loss of amino acid osmolytes. To isolate anion currents, we used CsCl as the major electrolyte in patch electrode and bath solutions and blocked residual cation currents with NiCl2and tetraethylammonium. Anion currents were activated by extracellular ATP with a Kmof 70 μM and increased over fourfold during several minutes of ATP exposure, reaching a maximum after 9.0 min (SD 4.2). The currents were blocked by inhibitors of nucleotide receptors and volume-regulated anion channels (VRAC). Currents showed outward rectification and inactivation at highly depolarizing membrane potentials, characteristics of swelling-activated anion currents. P2X agonists failed to activate the anion current, and an inhibitor of P2X receptors did not block the effect of ATP. Furthermore, current activation was observed with extracellular ADP and 2-(methylthio)adenosine 5′-diphosphate, a P2Y1receptor-specific agonist. Much less current activation was observed with extracellular UTP, suggesting the response is mediated predominantly by P2Y1receptors. ATP caused a dose-dependent loss of taurine and alanine that could be blocked by inhibitors of VRAC. ATP did not inhibit the taurine uptake transporter. Thus extracellular ATP triggers a loss of intracellular organic osmolytes via activation of anion channels. This mechanism may facilitate neuronal volume homeostasis during cytotoxic edema.
- 1 December 2008
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 295 (6) , C1550-C1560
Purinergic activation of anion conductance and osmolyte efflux in cultured rat hippocampal neurons
The majority of mammalian cells demonstrate regulatory volume decrease (RVD) following swelling caused by hyposmotic exposure. A critical signal initiating RVD is activation of nucleotide receptors by ATP. Elevated extracellular ATP in response to cytotoxic cell swelling during pathological conditions also may initiate loss of taurine and other intracellular osmolytes via anion channels. This study characterizes neuronal ATP-activated anion current and explores its role in net loss of amino acid osmolytes. To isolate anion currents, we used CsCl as the major electrolyte in patch electrode and bath solutions and blocked residual cation currents with NiCl2and tetraethylammonium. Anion currents were activated by extracellular ATP with a Kmof 70 μM and increased over fourfold during several minutes of ATP exposure, reaching a maximum after 9.0 min (SD 4.2). The currents were blocked by inhibitors of nucleotide receptors and volume-regulated anion channels (VRAC). Currents showed outward rectification and inactivation at highly depolarizing membrane potentials, characteristics of swelling-activated anion currents. P2X agonists failed to activate the anion current, and an inhibitor of P2X receptors did not block the effect of ATP. Furthermore, current activation was observed with extracellular ADP and 2-(methylthio)adenosine 5′-diphosphate, a P2Y1receptor-specific agonist. Much less current activation was observed with extracellular UTP, suggesting the response is mediated predominantly by P2Y1receptors. ATP caused a dose-dependent loss of taurine and alanine that could be blocked by inhibitors of VRAC. ATP did not inhibit the taurine uptake transporter. Thus extracellular ATP triggers a loss of intracellular organic osmolytes via activation of anion channels. This mechanism may facilitate neuronal volume homeostasis during cytotoxic edema.
- Open Access
- 8 February 2006
- Published by Wiley in Journal of Neurochemistry
- Vol. 96 (5) , 1375-1389
Regulation of taurine transport in rat hippocampal neurons by hypo‐osmotic swelling
Taurine, an important mediator of cellular volume regulation in the central nervous system, is accumulated into neurons and glia by means of a highly specific sodium‐dependent membrane transporter. During hyperosmotic cell shrinkage, net cellular taurine content increases as taurine transporter activity is enhanced via elevated gene expression of the transporter protein. In hypo‐osmotic conditions, taurine is rapidly lost from cells by means of taurine‐conducting membrane channels. We reasoned that changes in taurine transporter activity also might accompany cell swelling to minimize re‐accumulation of taurine from the extracellular space. Thus, we determined the kinetic and pharmacological characteristics of neuronal taurine transport and the response to osmotic swelling. Accumulation of radioactive taurine is strongly temperature dependent and occurs via saturable and non‐saturable pathways. At concentrations of taurine expected in extracellular fluidin vivo, 98% of taurine accumulation would occur via the saturable pathway. This pathway obeys Michaelis–Menten kinetics with aKmof 30.0 ± 8.8 μm(mean ± SE) andJmaxof 2.1 ± 0.2 nmol/mg protein min. The saturable pathway is dependent on extracellular sodium with an effective binding constant of 80.0 ± 3.1 mmand a Hill coefficient of 2.1 ± 0.1. This pathway is inhibited by structural analogues of taurine and by the anion channel inhibitors, 4,4′‐diisothiocyanostilbene‐2, 2′‐disulfonic acid (DIDS) and 5‐nitro‐2‐(3 phenylpropylamino) benzoic acid (NPPB). NPPB, but not DIDS, also reduces the ATP content of the cell cultures. Osmotic swelling at constant extracellular sodium concentration reduces theJmaxof the saturable transport pathway by approximately 48%, increasesKdifffor the non‐saturable pathway by 77%, but has no effect on cellular ATP content. These changes in taurine transport occurring in swollen neuronsin vivowould contribute to net reduction of taurine content and resulting volume regulation.
- 8 February 2006
- Published by Wiley in Journal of Neurochemistry
- Vol. 96 (5) , 1375-1389
Open AccessRegulation of taurine transport in rat hippocampal neurons by hypo‐osmotic swelling
Taurine, an important mediator of cellular volume regulation in the central nervous system, is accumulated into neurons and glia by means of a highly specific sodium‐dependent membrane transporter. During hyperosmotic cell shrinkage, net cellular taurine content increases as taurine transporter activity is enhanced via elevated gene expression of the transporter protein. In hypo‐osmotic conditions, taurine is rapidly lost from cells by means of taurine‐conducting membrane channels. We reasoned that changes in taurine transporter activity also might accompany cell swelling to minimize re‐accumulation of taurine from the extracellular space. Thus, we determined the kinetic and pharmacological characteristics of neuronal taurine transport and the response to osmotic swelling. Accumulation of radioactive taurine is strongly temperature dependent and occurs via saturable and non‐saturable pathways. At concentrations of taurine expected in extracellular fluidin vivo, 98% of taurine accumulation would occur via the saturable pathway. This pathway obeys Michaelis–Menten kinetics with aKmof 30.0 ± 8.8 μm(mean ± SE) andJmaxof 2.1 ± 0.2 nmol/mg protein min. The saturable pathway is dependent on extracellular sodium with an effective binding constant of 80.0 ± 3.1 mmand a Hill coefficient of 2.1 ± 0.1. This pathway is inhibited by structural analogues of taurine and by the anion channel inhibitors, 4,4′‐diisothiocyanostilbene‐2, 2′‐disulfonic acid (DIDS) and 5‐nitro‐2‐(3 phenylpropylamino) benzoic acid (NPPB). NPPB, but not DIDS, also reduces the ATP content of the cell cultures. Osmotic swelling at constant extracellular sodium concentration reduces theJmaxof the saturable transport pathway by approximately 48%, increasesKdifffor the non‐saturable pathway by 77%, but has no effect on cellular ATP content. These changes in taurine transport occurring in swollen neuronsin vivowould contribute to net reduction of taurine content and resulting volume regulation.